Yahoo Web Search

    33.50N/A (N/A%)

    at Mon, Dec 03, 2018, 11:36AM EST - U.S. Markets open in 4 hrs 17 mins

    Pre Mkt N/A

    • Ask Price 0.00
    • Bid Price 0.00
    • P/E 31.57
    • 52 Wk. High 33.50
    • 52 Wk. Low 0.00
    • Mkt. Cap 13.08B
  1. Web results

  2. Sumitomo Dainippon Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical ...

  3. Sumitomo Dainippon Pharma Co., Ltd. v. Emcure Pharmaceuticals ...

    law.justia.com/cases/federal/appellate-courts/...Cached

    Sumitomo Dainippon Pharma Co. and Sunovion Pharmaceuticals Inc. own U.S. Patent No. 5,532,372. The ’372 patent relates generally to “novel imide compounds and their acid addition salts” that are useful as antipsychotic agents. ’372 patent col. 1 ll. 8–12.

  4. Sumitomo Dainippon Pharma Co., Ltd. Corporate Profile

    www.ds-pharma.com/profile/profile/pdf/ecp...

    Befitting Sumitomo Dainippon Pharma’s tenth anniversary of the merger, “Innovation today, healthier tomorrows” is the global slogan adopted by four pharmaceutical companies of Sumitomo Dainippon Pharma group (Sumitomo Dainippon Pharma, Sunovion Pharmaceuticals, Boston Biomedical, and Sumitomo Pharmaceuticals (Suzhou)).

  5. Sumitomo Dainippon Pharma Co. Ltd. - MarketWatch

    www.marketwatch.com/investing/stock/4506

    Sumitomo Dainippon Pharma Co., Ltd. engages in manufacturing, sale, import and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments.

  6. Sumitomo Dainippon Pharma - Wikipedia

    en.wikipedia.org/wiki/Dainippon_Pharmaceutical_Co.Cached

    Sumitomo Dainippon Pharma Co., Ltd. (大日本住友製薬株式会社, Dainippon Sumitomo Seiyaku Kabushiki-Gaisha) is a pharmaceutical company based in Japan.Its ...

  7. SUMITOMO DAINIPPON PHARMA CO LTD ADR 2018 Q1 - Results ...

    seekingalpha.com/article/4192012-sumitomo...

    The following slide deck was published by SUMITOMO DAINIPPON PHARMA CO LTD ADR in conjunction with their 2018 Q1 earnings call.

  8. Sumitomo Dainippon Pharma Co. v. Emcure Pharmaceuticals Ltd. No Need to Resolve Full Claim Scope Upon Determining Coverage Over Dispositive Compound Fed Cir affirms stipulated judgment of infringement in Hatch-Waxman case.

  9. United States Court of Appeals for the Federal Circuit

    www.cafc.uscourts.gov/sites/default/files/opinions...

    SUMITOMO DAINIPPON PHARMA CO. v. EMCURE PHARM. LTD. 3 . active pharmaceutical ingredient in each party’s commer-cial product, we need not determine what else falls within the claim’s ambit to resolve thepresent dispute. We affirm. I . Stereochemistry is the study of a molecule’s three-dimensional structure. Stereoisomers are molecules with

  10. Sunovion Pharmaceuticals Inc. leads the way to a healthier tomorrow by creating medicines for respiratory diseases and central nervous system disorders.